Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1 weight-loss ...

The trial of 2,700 patients with increased cardiovascular risk showed that Foundayo lowered ‌the risk of heart attack, stroke ...

Wall Street met with satisfaction but not surprise Eli Lilly and Co.’s undeniably positive top-line results from the phase III Achieve-4 study testing the efficacy and safety of Foundayo (orforglipron ...

Larissa Banitt is a registered nurse who combines her English and Nursing degrees in writing health content. She has worked on the floor on a medical-surgical unit and currently works providing care ...

Continuous glucose monitoring in the GRADE trial shows that incretin-based drugs such as sitagliptin and liraglutide produce the most stable glycemic profiles and show the lowest hypoglycemia risk.

If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...